Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Bausch Health Companies Inc (BHC.TO)

Bausch Health Companies Inc (BHC.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Stocks in play: Bausch Health Companies Inc.

Along with its global aesthetic business, Solta Medical, today announced the successful completion of ...

BHC.TO : 9.38 (-2.49%)
TSX Gains by Noon

Canada's main stock index inched upward by noon on Thursday, led by technology and materials sectors, ...

BHC.TO : 9.38 (-2.49%)
Bausch: Q3 Earnings Snapshot

Bausch: Q3 Earnings Snapshot

BHC.TO : 9.38 (-2.49%)
Stocks in play: Bausch Health Companies Inc.

Announced the results of the special meeting of shareholders held on October 7. At the Shareholders ...

BHC.TO : 9.38 (-2.49%)
Stocks in play: Bausch Health Companies Inc.

Will release third-quarter 2025 financial results after market close on Wednesday, October 29. Bausch ...

BHC.TO : 9.38 (-2.49%)
Central Bank Meetings Throw Scare into Investors

Canada's benchmark stock index fell on Tuesday, dragged down by gold mining and material shares, with ...

BHC.TO : 9.38 (-2.49%)
Bausch Health Completes Acquisition of DURECT Corporation, Expanding Late-stage Liver Disease Portfolio

The transaction adds larsucosterol, an FDA Breakthrough Therapy for alcohol-associated hepatitis with a registrational Phase 3 clinical trial in development, to Bausch Health's hepatology pipeline

DRRX : 1.9100 (-1.04%)
BHC.TO : 9.38 (-2.49%)
BHC : 6.79 (-2.72%)
TSX Hangs onto Gains

Stocks aped their American cousins Tuesday, with gains in the oil patch overcoming setbacks in industrial ...

BHC.TO : 9.38 (-2.49%)
Rate Cut Hope Buoys Stocks Tuesday

Equities in Toronto sprang up Tuesday to begin a short week, with much of the momentum coming from gold ...

BHC.TO : 9.38 (-2.49%)
Bausch: Q2 Earnings Snapshot

Bausch: Q2 Earnings Snapshot

BHC.TO : 9.38 (-2.49%)

Barchart Exclusives

Trump’s Greenland Threats Scaring You Off? Buy This Dividend Stock as a Hedge
Trump's threats to seize Greenland have led to a selloff in risk assets while precious metals have rallied amid the flight to safe-haven assets. Agnico-Eagle Mines is a good dividend stock to buy amid the geopolitical turmoil. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar